Demographic and clinical characteristics associated with utilization of alcohol use disorder treatment in a multicenter study of patients with alcohol‐associated cirrhosis
Patients with alcohol-associated cirrhosis who were younger or had anxiety/depression and problematic drinking were more likely to utilize AUD treatment. To improve AUD treatment utilization, targeted outreach to patients less likely to receive care and the provision of integrated ALD and AUD treatment is warranted.
Authors
- Robert J. Wong (ORCID: https://orcid.org/0000-0002-8923-2806)
- Ramsey Cheung (ORCID: https://orcid.org/0000-0002-0211-7013)
- Jeremy W. Luk (ORCID: https://orcid.org/0000-0002-9061-1555)
- Derek D. Satre (ORCID: https://orcid.org/0000-0002-4228-1504)
- Alexander Monto (ORCID: https://orcid.org/0000-0002-2710-6871)
- Meimei Liao (ORCID: https://orcid.org/0000-0003-4334-5861)
- Steven L. Batki (ORCID: https://orcid.org/0000-0002-4950-4563)
- Hannah R. Snyder (ORCID: https://orcid.org/0000-0003-2853-3557)
- Nghiem B. Ha (ORCID: https://orcid.org/0000-0002-1980-1807)
- Michael J. Ostacher (ORCID: https://orcid.org/0000-0003-0353-7535)
- William Hua (ORCID: https://orcid.org/0000-0001-9335-6417)
- Mandana Khalili (ORCID: https://orcid.org/0000-0001-9178-9139)
- Priti I. Parekh
- D. Andrew Tompkins (ORCID: https://orcid.org/0000-0002-2112-2299)
- Amy M. Shui (ORCID: https://orcid.org/0000-0002-8243-6910)
- Taylor Fakadej
- Christina G. Haight
Institutions
- San Francisco General Hospital (US)
- Kaiser Permanente (US)
- University of California, San Francisco (US)
- VA Palo Alto Health Care System (US)
- National Institute on Alcohol Abuse and Alcoholism (US)
- San Francisco VA Health Care System (US)
- Stanford University (US)
Publication Details
- Journal
- Alcohol Clinical and Experimental Research
- Published
- 2024-12-04
- DOI
- https://doi.org/10.1111/acer.15500
- Citations
- 6
- Primary Topic
- Alcohol Consumption and Health Effects
- Type
- article
- Field-Weighted Citation Impact
- 2.55
Funders
- American Association for the Study of Liver Diseases
- Gilead Sciences
- Intercept Pharmaceuticals
- National Institutes of Health
- University of California, San Francisco
- National Institute on Alcohol Abuse and Alcoholism
- National Institute of Diabetes and Digestive and Kidney Diseases
- Liver Center, University of California, San Francisco